Family

+

−

• No Family data available.

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
CHANG GUNG UNIVERSITY	NO 259 WENHUA 1ST RD GUISHAN DIST TAOYUAN CITY 333 R O C

International Classification(s)

• A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....
• C12N:MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF

• 2016 Application Filing Year
• A61K Class
• 19101 Applications Filed
• 13019 Patents Issued To-Date
• 68.16 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Cheng, Ann-Joy	Taoyuan City, TW	10	4
# of filed Patents : 10 Total Citations : 4
Lu, Ya-Ching	New Taipei City, TW	3	1
# of filed Patents : 3 Total Citations : 1

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 0 Citation Count
• A61K Class

• 0 % this patent is cited more than
• 8 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
7.5 Year Payment	$3600.00	$1800.00	$900.00	Apr 5, 2025
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Apr 5, 2029

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 7.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

Full Text

US Patent Application No: 2017/0283,808

MIR-520B SEQUENCE FOR INHIBITING CANCER GROWTH AND SPREAD AND MEDICINE THEREFOR

---

Abstract

---

A miR-520b sequence for inhibiting cancer growth and spread includes miR-520b sequence for inhibiting cancer growth and spread wherein the miR-520b sequence is 5′-AAAGUGCUUCCUUUUAGAGGGtt-3′ of SEQ ID NO:2. A medicine for inhibiting cancer growth and spread includes a medicinal preparation including miR-520b substrate and medical agent wherein the miR-520b substrate is miR-520b sequence and has concentration of 50 μM, and the miR-520b sequence is 5′-AAAGUGCUUCCUUUUAGAGGGtt-3′ of SEQ ID NO:2.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

• No Legal Status data available.